National and Kapodistrian University of Athens
Μελέτη των ειδικών έναντι του κυτταρομεγαλοϊού κυτταροτοξικών (CD8+) λεμφοκυττάρων, μετά απο αλλογενή μεταμόσχευση αρχεγόνων αιμοποιητικών κυττάρων σε παιδιατρικούς ασθενείς, και διερεύνηση του ρόλου τους στην κλινική πράξη
Abstract
dc:descriptionCytomegalovirus (CMV) is a ubiquitous pathogen, which, is not eradicated followingacute infection, but remains latent in the host. Maintenance of equilibrium between the virus andthe immune mechanisms of the host, mainly CD4+ and CD8+ cellular immune responses, isessential. In case of disruption of this equilibrium, as in the Haematopoietic Stem CellTransplantation (HSCT) setting, there is a substantial risk of development of potentially lethalCMV disease, which is still of great concern, despite the preemptive administration of antiviralagents. Drug toxicity, disruption of reconstitution of CMV specific T-cell responses by antiviralagents and emergence of resistant CMV strains, are to be accounted for this. Optimization ofantiviral treatment protocols requires additional laboratory indices for (1) disease progressionand treatment success and (2) identification of patients at risk of end-organ CMV disease.Immune reconstitution of CMV specific immune responses post HSCT has been widelystudied, especially after the invention of MHC tetramers, which have provided a fast method forthe quantification of antigen specific CD8+ cells and enabled the simultaneous study ofadditional indices. Even though prompt immune reconstitution of CMV specific CD4+ andCD8+ T cells has been shown to protect from CMV reactivations and end organ disease, there isstill no consensus as to the role of the immune reconstitution studies in shaping antiviraltreatment. Main points of disagreement concern the significance of functional methods (mainlyfor cytokine production) and the identification of immunodominant peptides.The present study aimed to investigate the value of the assessment of CMV specificimmune reconstitution in the paediatric HSCT setting, using pp65 NLVPLMATV loaded MHCA*0201 tetramers, in conjunction with the simultaneous study of CD45RA and CD62Lexpression, which has been correlated with cell function. CD28 expression was additionallystudied on total CD8+ cells.We studied 11 consecutive MHC A*0201+ children submitted to allogeneic HSCT in“Aghia Sophia” Children’s Hospital, the main additional selection criterion being CMVseropositivity of either the donor or recipient. CMV pp65 specific CD8+ cells were studiedbefore and 5, 7, 9, 11 and 15 weeks post HSCT. Donor or graft specimens were also studied. Theaforementioned laboratory indices were correlated with occurrence of CMV infection (asassessed by pp65 antigenaemia or DNAaemia) and with clinical course. CMV reactivation wasdiagnosed in 5 patients, in 3 of whom the infection was recurrent/persistent. No case with CMVdisease was recorded.The main findings were as follows:(1) pp65 specific CD8+ cell reconstitution, as well as CD45RA and CD62L expressionpatterns, were greatly influenced by the occurrence of CMV reactivation. Accordingly, 4different patterns of CMV specific reconstitution are proposed. (2) Based on the aforementioned observation, samples were separated into two groups,according to prior occurrence of CMV reactivation, which is proposed as an essential criterionfor the interpretation of the immune reconstitution results.(3) In case of no prior reactivation, rapid reconstitution of pp65 specific CD8+ cells wassignificantly correlated with protection against persistent/recurrent CMV infection. However,failure to detect pp65 specific CD8+ cells, prior to reactivation, could not identify patients atrisk, a finding that could be attributed to the possibility of an alternative immunodominantepitope specificity in many patients.(4) Elevation of CD45RA expression rate on CMV specific CD8+ cells, when comparedto CD45RA expression on total CD8+, was observed in samples preceding a CMV reactivation.(5) In case of prior occurrence of CMV reactivation, enumeration of pp65 specificCD8+ cells did not seem to predict recurrent/persistent CMV infection. However, it is postulatedthat their numerical elevation, following a reactivation episode, may denote an underlying abilityto mount an antigen specific immune response and, thus, protection against end-organ CMVdisease.(6) Following an episode of CMV reactivation, the risk of future additional episodeswas related to (a) low CD3 count, (b) a shift towards central memory and effector CD8+ cells,with low percentage of naïve CD8+ cells, (c) elevation of CD8dim cell proportion to CD8++cells. Further studies are needed to test if the above could constitute risk factors for futurereactivations.The above results are summarized in a proposed algorithm for the assessment ofimmune reconstitution studies. Further HSCT cases are being assessed to evaluate theaforementioned results and to identify additional risk factors.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzanoudaki, Marianna
- Τζανουδάκη, Μαριάννα
Subjects
dc:subject × 18- Κυτταρομεγαλοϊός
- Αντιγονοειδικά κυτταροτοξικά λεμφοκύτταρα
- Μεταμόσχευση αιμοποιητικών κυττάρων
- MHC τετραμερή
- Παιδιά
- Φωσφοπρωτεΐνη G5 (PPG5)
- Cytomegalovirus
- Antigen specific cytotoxic lymphocytes
- Hematopoietic stem cell transplantation
- MHC tetramers
- Children
- Phosphoprotein G5 (PPG5)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41139